Healthcare New Lows: VIVUS, Inc. (NASDAQ:VVUS), Haemonetics Corporation (NYSE:HAE), Mindray Medical International Ltd (ADR) (NYSE:MR), Onconova Therapeutics Inc (NASDAQ:ONTX)

VIVUS, Inc. (NASDAQ:VVUS) is the Mountain View, California-based biopharma company, which has a line of drugs fighting sleep apnea to overweight or diabetes. One of its currently popular drugs, used for weight-management and fighting obesity is Qsymia. However, this is a drug recommended with a diet which is calorie-deficient. The efficacy of the drug is optimized when physical activity too is increased or a strict exercise regime is followed. The initial body mass index in adults at 30 or higher are also indicative of two conditions – hypertension or type 2 diabetes mellitus and higher cholesterol. VIVUS, Inc. (NASDAQ:VVUS) shares after opening at $5.92 moved to $5.92 on last trade day and at the end of the day closed at $5.60. Company price to sales ratio in past twelve months was calculated as 7.07 and price to cash ratio as 1.67. VIVUS, Inc. (NASDAQ:VVUS) showed a negative weekly performance of -6.51%.

Haemonetics Corp. (NYSE:HAE) announced that it was not selected to supply The American Red Cross with certain whole blood collection components. The Company was informed that a competitor was chosen to supply these products on an exclusive basis.  Haemonetics Corporation (NYSE:HAE) shares fell -9.63% in last trading session and ended the day on $33.61. HAE return on equity ratio is recorded as 20.80% and its return on assets is 11.10%. Haemonetics Corporation (NYSE:HAE) yearly performance is -17.62%.

On March 7, 2014 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer, and marketer of medical devices worldwide, announced that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share). Each Mindray ADS corresponds to one ordinary share. The record date for Mindray’s ordinary shares (previously announced as March 8, 2014) will also be March 14, 2014. Mindray Medical International Ltd (ADR) (NYSE:MR) shares moved down -3.03% in last trading session and was closed at $30.41, while trading in range of $30.03-$31.76.Mindray Medical International Ltd (ADR) (NYSE:MR) year to date performance is -15.06%.

Shares of Onconova Therapeutics (NASDAQ:ONTX) were the recipient of a large decrease in short interest in the month of January. As of February 28th, there was short interest totalling 1,272,556 shares, a decrease of 24.2% from the February 14th total of 1,679,370 shares, American Banking & Market News reports. Based on an average daily volume of 800,615 shares, the short-interest ratio is currently 1.6 days. Approximately 11.2% of the shares of the company are short sold. Onconova Therapeutics Inc (NASDAQ:ONTX) weekly performance is -8.37%. On last trading day company shares ended up $6.90. Onconova Therapeutics Inc (NASDAQ:ONTX) distance from 50-day simple moving average is -38.01%. Analysts mean target price for the company is $11.50.